Dr. Michael Herlich, MD

NPI: 1891748109
Total Payments
$3,077
2024 Payments
$261.69
Companies
23
Transactions
183
Medicare Patients
5,196
Medicare Billing
$1.0M

Payment Breakdown by Category

Food & Beverage$3,077 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,077 183 100.0%

Top Paying Companies

Company Total Records Latest Year
Impulse Dynamics (USA) Inc. $487.57 15 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $416.38 33 $0 (2021)
Amgen Inc. $400.45 29 $0 (2021)
Novartis Pharmaceuticals Corporation $397.37 30 $0 (2020)
BOSTON SCIENTIFIC CORPORATION $385.66 4 $0 (2018)
Janssen Pharmaceuticals, Inc $181.53 13 $0 (2020)
Kowa Pharmaceuticals America, Inc. $140.37 10 $0 (2021)
Boehringer Ingelheim Pharmaceuticals, Inc. $113.14 7 $0 (2021)
AstraZeneca Pharmaceuticals LP $107.25 9 $0 (2021)
E.R. Squibb & Sons, L.L.C. $89.20 7 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $261.69 7 Impulse Dynamics (USA) Inc. ($261.69)
2023 $241.08 9 Impulse Dynamics (USA) Inc. ($225.88)
2021 $260.69 20 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($139.73)
2020 $375.32 28 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($157.12)
2019 $429.12 32 Amgen Inc. ($138.91)
2018 $1,012 54 BOSTON SCIENTIFIC CORPORATION ($367.28)
2017 $497.26 33 Novartis Pharmaceuticals Corporation ($159.96)

All Payment Transactions

183 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
11/19/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $68.00 General
Category: Cardiovascular Device
08/14/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $30.90 General
Category: Cardiovascular Device
08/07/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $34.41 General
Category: Cardiovascular Device
05/02/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $25.83 General
Category: Cardiovascular Device
03/26/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $38.25 General
Category: Cardiovascular Device
03/14/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $32.12 General
Category: Cardiovascular Device
02/19/2024 Impulse Dynamics (USA) Inc. Optimizer (Device), Optimizer Food and Beverage Cash or cash equivalent $32.18 General
Category: Cardiovascular Device
11/09/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $41.28 General
Category: Cardiovascular Device
08/08/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $18.22 General
Category: Cardiovascular Device
06/27/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $31.88 General
Category: Cardiovascular Device
05/09/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $27.91 General
Category: Cardiovascular Device
04/26/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $35.00 General
Category: Cardiovascular Device
04/11/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $19.61 General
Category: Cardiovascular Device
03/13/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $28.90 General
Category: Cardiovascular Device
02/13/2023 Impulse Dynamics (USA) Inc. OPTIMIZER (Device), OPTIMIZER Food and Beverage Cash or cash equivalent $23.08 General
Category: Cardiovascular Device
01/06/2023 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $15.20 General
Category: Cardiology/Vascular Diseases
09/15/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $12.82 General
Category: Electromedical and Electrotherapeutic Apparatus
08/25/2021 Merck Sharp & Dohme Corporation VERQUVO (Drug) Food and Beverage In-kind items and services $13.63 General
Category: CARDIOVASCULAR
08/09/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $10.48 General
Category: Electromedical and Electrotherapeutic Apparatus
07/28/2021 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $12.29 General
Category: DIABETES
07/27/2021 Kowa Pharmaceuticals America, Inc. Livalo (Drug) Food and Beverage Cash or cash equivalent $14.39 General
Category: Cardiovascular
07/22/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $11.32 General
Category: Electromedical and Electrotherapeutic Apparatus
07/19/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $12.53 General
Category: Electromedical and Electrotherapeutic Apparatus
07/15/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $11.37 General
Category: Electromedical and Electrotherapeutic Apparatus
07/01/2021 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $11.71 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 20 2,723 3,465 $1.2M $557,396
2020 21 2,473 3,199 $1.1M $479,031
Total Patients
5,196
Total Services
6,664
Medicare Billing
$1.0M
Procedure Codes
41

All Medicare Procedures & Services

41 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
78492 Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress Office 2021 164 164 $500,261 $235,556 47.1%
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries Office 2021 164 167 $180,400 $104,472 57.9%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 291 293 $161,150 $53,367 33.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 401 452 $103,068 $48,737 47.3%
J2785 Injection, regadenoson, 0.1 mg Office 2021 191 764 $45,840 $36,375 79.4%
93880 Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck Office 2021 109 109 $40,434 $19,851 49.1%
78452 Nuclear medicine study of vessels of heart using drugs or exercise multiple studies Office 2021 37 37 $35,557 $16,052 45.1%
93017 Exercise or drug-induced heart and blood vessel stress test with ekg tracing and monitoring Office 2021 200 200 $28,600 $6,070 21.2%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 422 475 $21,375 $5,959 27.9%
93016 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision Office 2021 285 285 $34,200 $5,089 14.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 32 32 $10,720 $4,756 44.4%
93351 Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report Office 2021 21 21 $11,907 $4,532 38.1%
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose Office 2021 36 37 $4,210 $3,172 75.3%
93925 Ultrasound study of arteries and arterial grafts of both legs Office 2021 13 13 $6,347 $2,857 45.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 16 16 $5,026 $2,567 51.1%
93018 Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report Office 2021 201 201 $13,869 $2,534 18.3%
93224 Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report Office 2021 28 28 $7,812 $1,869 23.9%
99439 Chronic care management services, each additional 20 minutes of clinical staff time per calendar month Office 2021 14 46 $3,220 $1,524 47.3%
99490 Chronic care management services, first 20 minutes of clinical staff time per calendar month Office 2021 14 41 $4,920 $1,483 30.1%
J0280 Injection, aminophyllin, up to 250 mg Office 2021 84 84 $2,520 $575.41 22.8%
78492 Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress Office 2020 133 133 $408,044 $186,457 45.7%
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries Office 2020 133 172 $146,300 $84,679 57.9%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2020 280 280 $154,000 $51,051 33.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 381 462 $101,178 $38,376 37.9%
J2785 Injection, regadenoson, 0.1 mg Office 2020 173 692 $41,840 $32,263 77.1%

About Dr. Michael Herlich, MD

Dr. Michael Herlich, MD is a Cardiovascular Disease healthcare provider based in Haddon Heights, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891748109.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Herlich, MD has received a total of $3,077 in payments from pharmaceutical and medical device companies, with $261.69 received in 2024. These payments were reported across 183 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,077).

As a Medicare-enrolled provider, Herlich has provided services to 5,196 Medicare beneficiaries, totaling 6,664 services with total Medicare billing of $1.0M. Data is available for 2 years (2020–2021), covering 41 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Haddon Heights, NJ
  • Active Since 05/18/2006
  • Last Updated 12/10/2007
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1891748109

Products in Payments

  • LifeVest (Device) $416.38
  • ENTRESTO (Drug) $397.37
  • WATCHMAN (Device) $385.66
  • Corlanor (Drug) $295.86
  • Optimizer (Device) $261.69
  • OPTIMIZER (Device) $225.88
  • XARELTO (Drug) $181.53
  • Livalo (Drug) $140.37
  • BRILINTA (Drug) $108.37
  • Repatha (Biological) $104.59
  • ELIQUIS (Drug) $101.15
  • JARDIANCE (Drug) $79.90
  • Vascepa (Drug) $77.44
  • PRADAXA (Drug) $33.24
  • BYSTOLIC (Drug) $31.87
  • MULTAQ (Drug) $29.34
  • VERQUVO (Drug) $28.24
  • PRALUENT (Drug) $22.94
  • CHANTIX (Drug) $22.93
  • JUXTAPID (Drug) $15.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Haddon Heights